Pheiron
Thore Buergel is the Co-Founder & CEO of Pheiron, utilizing AI and population-scale data for drug research. Previously, Thore has worked as a Honorary Lecturer at UCL and conducted their PhD at Charité focusing on risk modeling in primary prevention. Thore has also worked as an Independent Consultant at YEARS, conducted research at Stanford University and EMBL-EBI, and studied at Heidelberg University and Freie Universität Berlin.
This person is not in any teams
Pheiron
We radically improve the probability of success in drug development by getting right what really matters: human evidence to back the target and prognostic disease signatures to define the population.